GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Asston Pharmaceuticals Ltd

Asston Pharmaceuticals appoints CFO and two independent directors — board changes effective 30 March 2026

MANAGEMENT ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 30 Mar 2026, 04:50 PM IST  ·  BSE ID: 69583ad2-d5c7-4a75-9503-6c492a9d8580
View Original BSE Filing (PDF)
💡
In Simple Terms
The company hired a new Chief Financial Officer and two new directors to its board, effective immediately.
🤖 AI Summary
  • Mr. Sumit Pawar appointed as Chief Financial Officer effective 30 March 2026
  • Mr. Yashvardhan Tupe (DIN 08759617) appointed Additional Non-Executive Director effective 30 March 2026
  • Mr. Sandip Sharma (DIN 11627247) appointed Additional Non-Executive Independent Director effective 30 March 2026
  • Extraordinary General Meeting scheduled for 28 April 2026 at 12:30 PM via video conferencing
🔢 Key Numbers - exact figures from BSE filing, not rounded
CFO appointment effective date
30 March 2026
Non-Executive Director appointment effective date
30 March 2026
Independent Director appointment effective date
30 March 2026
Extraordinary General Meeting date
28 April 2026 at 12:30 PM
🏢 How This Affects the Company
⚙️
Operational Impact
CFO appointment strengthens finance function. Two director appointments expand board composition and oversight capacity with independent director addition.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must attend Extraordinary General Meeting on 28 April 2026 at 12:30 PM to approve board appointments if required by Articles.
👤
Who Is Affected
All shareholders of record are notified of board composition changes and EGM. Voting rights and governance participation affected by new independent director appointment.
🔍
Management Signal
Management is building out finance leadership and independent board oversight; CFO appointment suggests focus on regulatory compliance and financial governance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Extraordinary General Meeting outcome on 28 April 2026 — confirm shareholder approval of board additions
Filing of board composition changes on stock exchange — verify updated director details and biographies
Q4 FY26 financial results — assess CFO's first quarter reporting and financial controls implementation
LOW RISK Routine management appointments with no operational, financial, or strategic disruption. Independent director adds governance safeguard.
💡 Investor Takeaway
Asston Pharmaceuticals appointed three key personnel on 30 March 2026: CFO Sumit Pawar and two directors. Filing provides no financial data, business metrics, or operational context. Shareholder approval at 28 April EGM is required.
⚖️ Strengths & Concerns

✅ Positives

  • Independent director appointment adds external governance oversight to board structure and decision-making process
  • CFO appointment indicates management focus on financial controls and statutory compliance framework strengthening
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.